These considerations led us to investigate the ability of treatment with OA-NO2, the most potent PPAR-γ-activating NFA [11], to reduce the severity of inflammation and lung injury in a murine model of ALI induced by LPS. Here, PPARG is linked to acute respiratory distress syndrome.